Funding Rounds
Tenpoint Therapeutics

Tenpoint Therapeutics Series A (2023, $70M)

Tenpoint Therapeutics

Restore sight by replacing engineered cell-based therapeutics.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $70.00M

Investors